Related references
Note: Only part of the references are listed.Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review
Yantian Cao et al.
STEM CELL RESEARCH & THERAPY (2021)
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
Brian G. Feagan et al.
LANCET (2021)
Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2020)
Outcome of Ileal Pouch-anal Anastomosis in Patients With Indeterminate Colitis: A Systematic Review and Meta-analysis
Sameh Hany Emile et al.
JOURNAL OF CROHNS & COLITIS (2020)
Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids
Robert Salameh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
The Efficacy and Safety of Mesalamine and Probiotics in Mild-to-Moderate Ulcerative Colitis: A Systematic Review and Meta-Analysis
Chunying Tian et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis
Thomas Ochsenkuehn et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials
Lucas Guillo et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Nonbiologic Immune Suppression in Ulcerative Colitis
Valerie Heron et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)
Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis
Davide Giuseppe Ribaldone et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2020)
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Vince B. C. Biemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis
Jacob E. Ollech et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
B. E. Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Epidemiology of Indeterminate Colitis in the United States Between 2014 and 2019: A Population-Based National Study
Emad Mansoor et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis
Siddharth Singh et al.
GASTROENTEROLOGY (2019)
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis
Nghia Nguyen et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies
Julian Panes et al.
JOURNAL OF CROHNS & COLITIS (2018)
Long-term outcomes following ileal pouch-anal anastomosis in patients with indeterminate colitis
Uri Netz et al.
SURGERY (2018)
Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease
Stavroula A. Paschou et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
Kenneth F. Baker et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Long-Term Outcomes in Indeterminate Colitis Patients Undergoing Ileal Pouch-Anal Anastomosis: Function, Quality of Life, and Complications
Katharine L. Jackson et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study
Bruce E. Sands et al.
GASTROENTEROLOGY (2017)
Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis
Amy L. Lightner et al.
INFLAMMATORY BOWEL DISEASES (2017)
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inflammatory diseases and bone fragility
K. Briot et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN
Marina Aloi et al.
INFLAMMATORY BOWEL DISEASES (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Model for Identifying Cytomegalovirus in Patients With Inflammatory Bowel Disease
Jeffrey D. McCurdy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort
Stephan R. Vavricka et al.
INFLAMMATORY BOWEL DISEASES (2015)
A contemporary and critical appraisal of 'indeterminate colitis'
Robert D. Odze
MODERN PATHOLOGY (2015)
Treatment of IBD: Where We Are and Where We Are Going
Charles N. Bernstein
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Risk factors and management of osteoporosis in inflammatory bowel disease
Laura E. Targownik et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Characteristics of Inflammatory Bowel Disease Serology in Patients With Indeterminate Colitis
Siddharth P. Sura et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
Jacques Cosnes et al.
GASTROENTEROLOGY (2013)
Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease
Amit Assa et al.
JOURNAL OF CROHNS & COLITIS (2013)
Extraintestinal manifestations and complications in IBD
Claudia Ott et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis
Haruhiko Ogata et al.
INFLAMMATORY BOWEL DISEASES (2012)
Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis
Udayakumar Navaneethan et al.
JOURNAL OF CROHNS & COLITIS (2012)
Methotrexate for induction of remission in refractory Crohn's disease
John W. D. McDonald et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Systematic review: Clostridium difficile and inflammatory bowel disease
J. R. Goodhand et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Temporal Trends in Disease Outcomes Related to Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease
Ashwin N. Ananthakrishnan et al.
INFLAMMATORY BOWEL DISEASES (2011)
Treatment of inflammatory bowel disease (IBD)
Anand B. Pithadia et al.
PHARMACOLOGICAL REPORTS (2011)
Bone, Inflammation, and Inflammatory Bowel Disease
Manasi Agrawal et al.
Current Osteoporosis Reports (2011)
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus
K. R. Herrlinger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
New pathophysiological insights and modern treatment of IBD
Matthias A. Engel et al.
JOURNAL OF GASTROENTEROLOGY (2010)
A Prospective Evaluation of the Long-Term Outcome of Ileal Pouch-Anal Anastomosis in Patients with Inflammatory Bowel Disease-Unclassified and Indeterminate Colitis
Zuri A. Murrell et al.
DISEASES OF THE COLON & RECTUM (2009)
Frequency of indeterminate colitis in children and adults with IBD - a metaanalysis
Freerk Prenzel et al.
JOURNAL OF CROHNS & COLITIS (2009)
Indeterminate colitis: A review of the concept what's in a name?
Karel Geboes et al.
INFLAMMATORY BOWEL DISEASES (2008)
Treatment of inflammatory bowel disease: A review of medical therapy
Patricia L. Kozuch et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Role of colonoscopic biopsy in distinguishing between Crohn's disease and intestinal tuberculosis
R. Kirsch et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Diagnostic difficulties in inflammatory bowel disease pathology
RK Yantiss et al.
HISTOPATHOLOGY (2006)
Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: Outcomes and patterns of failure
CJ Brown et al.
DISEASES OF THE COLON & RECTUM (2005)
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:: A randomized, placebo-controlled study
G Järnerot et al.
GASTROENTEROLOGY (2005)
The strictured anastomosis: Successful treatment by corticosteroid injections - Report of three cases and review of the literature
PA Lucha et al.
DISEASES OF THE COLON & RECTUM (2005)
Oral methotrexate in ulcerative colitis
JRF Cummings et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Differentiating risk factors for acute and chronic pouchitis
JP Achkar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool
M Mylonaki et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
T Mimura et al.
GUT (2004)
Indeterminate colitis - Clinical spectrum of disease
R Burakoff
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Outcome of patients with indeterminate colitis undergoing a double-stapled ileal pouch-anal anastomosis
T Pishori et al.
DISEASES OF THE COLON & RECTUM (2004)
Infliximab in the treatment of medically refractory indeterminate colitis
KA Papadakis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Indeterminate colitis
K Geboes et al.
INFLAMMATORY BOWEL DISEASES (2003)
Indeterminate colitis - The real story
WG Rudolph et al.
DISEASES OF THE COLON & RECTUM (2002)
Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis
MT Dayton et al.
ARCHIVES OF SURGERY (2002)
The value of serologic markers in indeterminate colitis: A prospective follow-up study
S Joossens et al.
GASTROENTEROLOGY (2002)
The efficacy of methotrexate for maintaining remission in inflammatory bowel disease
AG Fraser et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis
L Navazo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Ileal pouch-anal anastomosis in patients with indeterminate colitis - Long-term results
CS Yu et al.
DISEASES OF THE COLON & RECTUM (2000)
6-Mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease
J Maté-Jiménez et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2000)
Share Paper
